SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus upcoming oncology milestones are driving attention, particularly the completed IMPACT pancreatic-cancer trial enrollment and expected data, alongside further REGAIN glioblastoma updates. Traders are broadly optimistic about the expanding pipeline, while some emphasize that larger datasets are still needed to validate the early results.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results, particularly resilient parks performance and improving streaming profitability, have reinforced bullish sentiment and prompted analyst upgrades. Traders remain divided, with some seeing a turnaround while others point to the stocks long stretch of weak, range-bound performance.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is pulling back after a strong run as traders position ahead of earnings, with some wary of recent SaaS-sector weakness and the stocks valuation. Others remain bullish on growth and AI-driven commerce, while security concerns appear in some bearish posts but are not the dominant discussion.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Attention centers on Candels planned Q4 BLA submission for CAN-2409 in localized prostate cancer and upcoming SITC pipeline data. Bulls see the clinical and regulatory milestones as potential catalysts, while skeptics point to the steep decline, CEO share sales, limited transparency, possible dilution and uncertainty about filing timing; some also blame broader biotech weakness and thin trading.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias early third-quarter report and raised full-year revenue guidance are driving attention, with continued LUPKYNIS sales growth supporting the results. Traders are split between viewing the report as solid execution and frustration that the shares fell despite it, compounded by confusion over whether management held an earnings call.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys shares are drawing attention after a sharp post-earnings rally despite revenue and EPS misses; traders are focusing on premium subscriber growth, stronger gross margin, and an upbeat fourth-quarter profit outlook. The move has surprised some investors, who question why the stock rose on a mixed report, while bulls see the guidance and improving ad revenue as the more important signals.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

ALAB is drawing attention amid a sharp pullback alongside other AI and semiconductor stocks, with traders citing stretched valuations, broad market pressure, and uncertainty ahead of earnings. The community is split between buyers treating the decline as an opportunity and bears warning that the stock remains overvalued and could fall further.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs large equity and warrant offering, alongside its Elisity acquisition, has put dilution and capital allocation at the center of the discussion as shares have sold off. Bulls see the financing and acquisitions as building a broader quantum platform, while critics question shareholder costs and execution; a Google quantum breakthrough has also lifted sector optimism, though traders disagree on whether that can overcome IONQ-specific concerns.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could weaken in 2027 has sparked concerns about pricing and CorMedixs largest revenue driver, contributing to a sharp selloff. Traders are divided over the impact: some see a serious commercial risk, while others argue DaVitas outlook is preliminary and point to CMS reimbursement estimates as a reason the reaction may be excessive.

NEAR Protocol (NEAR) is a cryptocurrency launched in 2020. NEAR Protocol has a current supply of 1,310,395,414. The last known price of NEAR Protocol is 4.30157975 USD and is up 6.10 over the last 24 hours. It is currently trading on 688 active market(s) with $1,245,620,491.67 traded over the last 24 hours. More information can be found at https://near.org/.

Near

Traders are watching a governance vote that could make NEAR less inflationary, with some viewing the tokenomics change as a potential catalyst. Sentiment is split: dip-buyers are accumulating, while cautious traders point to Bitcoin-linked weakness and liquidation risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis

ICU Medical, Neogen and Trulieve Cannabis offer distinct growth catalysts as medical products demand benefits from innovation, resilient procedures and evolving market opportunities.

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.

Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet

Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet Trulieve Repays $65 Million Mortgage Strengthening Balance SheetPR NewswireTALLAHASSEE, Fla., Oct. 7, 2026TALLAHASSEE, Fla., Oct. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp.(NYSE: TRLV) ("Trulieve" or "the Company"), a leading and...

Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026

Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026 Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026PR NewswireTALLAHASSEE, Fla., Oct. 6, 2026TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis...

MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case  

Equity

DEA Chief Judge Derek Julius paused the cannabis rescheduling case on Tuesday afternoon.


Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas

Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and TexasPR NewswireTALLAHASSEE, Fla., Sept. 28, 2026 Perpetual Royalty-Free License Covers Alien Labs and Connected...

Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices

Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion IndicesPR NewswireTALLAHASSEE, Fla., Sept. 22, 2026 Inclusion Marks Another Milestone as Trulieve Broadens U.S. Capital Markets Exposure TALLAHASSEE...

Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia

Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia PR Newswire TALLAHASSEE, Fla., Sept. 4, 2026 New DeKalb County location will host grand opening celebration Thursday, September 10TALLAHASSEE, Fla., Sept. 4, 2026...

Trulieve Announces September 2026 Event Participation

Trulieve Announces September 2026 Event Participation Trulieve Announces September 2026 Event Participation PR Newswire TALLAHASSEE, Fla., Sept. 2, 2026 TALLAHASSEE, Fla., Sept. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp.(NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing...

Happy Health Raises $75 Million for Healthcare in the Home: NYSE Content Update

Happy Health Raises $75 Million for Healthcare in the Home: NYSE Content Update Happy Health Raises $75 Million for Healthcare in the Home: NYSE Content Update PR Newswire NEW YORK, Aug. 18, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Aug. 18, 2026...

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Bearish Sentiment

<ul class="summary-bullets"><li>Rescheduling changes where marijuana sits under the federal Controlled Substances Act instead of legalizing it.</li><li>In April, the Justice Department moved two categories of marijuana to Schedule III: FDA-approved products that contain marijuana, and marijuana grown or sold under a qualifying state medical license.</li><li>The stay does not reject rescheduling or cancel the earlier medical-marijuana rule.</li></ul>The AdvisorShares Pure US Cannabis ETF (<a class="mention" data-mention="$MSOS" data-symbol-id="MSOS" href="https://stocktwits.com/symbol/MSOS" target="_blank">MSOS</a>) fell as much as about 8% after hours Tuesday after a federal judge paused the leftover case on reclassifying marijuana, including adult-use product, to Schedule III from Schedule I.Trulieve Cannabis (TRLV), one of the ETF’s largest holdings, finished regular trading at $12.41, up 0.6%, then traded as low as about $11, a drop of roughly 9% in extended hours.<h2 class="st-heading-2">What The Judge Ordered</h2>DEA Chief Judge Derek Julius paused the case on Tuesday afternoon. The public hearing ended in mid-July. He had been expected to send a recommendation to the DEA administrator next. That step is now on hold.On Sept. 28, three hearing participants who oppose broader rescheduling — DUID Victim Voices, Dr. Kenneth Finn, and the National Drug and Alcohol Screening Association — asked him to add a Sept. 23 Government Accountability Office report on drug-scheduling procedures to the record and to allow extra briefing. Julius said a stay was warranted while he decides whether to reopen the record. The government must respond by Oct. 13. Other parties may file replies by the same date.<h2 class="st-heading-2">What Rescheduling Means</h2>Rescheduling changes where marijuana sits under the federal Controlled Substances Act. It is not the same as legalizing it. Schedule I is the tightest box: high abuse potential and no accepted medical use. Marijuana has been listed there since 1970. Schedule III is looser. It covers drugs with accepted medical use and lower abuse potential than Schedule I or II. Moving a drug down the list does not take it off the list.In April, the Justice Department moved two categories of marijuana to Schedule III: FDA-approved products that contain marijuana, and marijuana grown or sold under a qualifying state medical license. The paused case is about the rest of the plant, including adult-use product.The stay does not reject rescheduling or cancel the earlier medical-marijuana rule. It delays a decision investors had treated as a near-term catalyst.<h2 class="st-heading-2">How Did <a class="mention" data-mention="$MSOS" data-symbol-id="MSOS" href="https://stocktwits.com/symbol/MSOS" target="_blank">MSOS</a>, TRLV Retail Traders React?</h2>On Stocktwits, retail sentiment around TRLV and <a class="mention" data-mention="$MSOS" data-symbol-id="MSOS" href="https://stocktwits.com/symbol/MSOS" target="_blank">MSOS</a> stayed within the bullish territory at he time of writing.“Broader rescheduling is less likely now,” a Stocktwits user wrote.<stembedurl>https://stocktwits.com/Alexsolstice/message/665384525</stembedurl>Another user dismissed the selloff, saying a rescheduling will come in the future.<stembedurl>https://stocktwits.com/Lboog27/message/665380883</stembedurl>TRLV has gained about 43% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/qure-stock-clocks-worst-day-in-over-10-months-four-year-huntington-s-data-spooks-investors-despite-stronger-three-year-filing-data/cZMZh6KRBWi">QURE Stock Clocks Worst Day In Over 10 Months: Four-Year Huntington’s Data Spooks Investors Despite Stronger Three-Year Filing Data</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Close-up of fresh cannabis plant on sunny day. Natural pattern is on green leaf. Organic hemp is growing at farm.

DEA Chief Judge Derek Julius paused the cannabis rescheduling case on Tuesday afternoon.

MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$10.28
Prev Close	$10.60
Open	$10.46
Dividend Yield	0.00%
50-Day Moving Average	$11.19
Beta	0.67
Avg. Volume	2.67M
PE Ratio	-4.18

52-Week High	$13.28
52-Week Low	$4.62
Market Capitalization	$1.98B
EPS (Annual)	-$0.6083
Price to Book	2.58
Revenue Per Employee	$236,236.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

TRLV Fundamentals